HTLV-I Infection: Clinical Trials

5 trials for HTLV-I Infection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 recruiting. 2 Phase 2, 1 Early Phase 1, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Early Phase 11Completed 1
Phase 11Completed 1

Follow HTLV-I Infection: new trials by email Literature Review of HTLV-I Infection trials Research Report on HTLV-I Infection

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Raltegravir for HAM/TSP
Raltegravir - HTLV-I Infection
Early Phase 1CompletedNational Institute of Neurological Disorders and Stroke (NINDS)192013-09-052023-03-30
Anti-Tac for Treatment of Leukemia
daclizumab - HTLV-I Infection, T Cell Leukemia
Phase 1 / Phase 2CompletedNational Cancer Institute (NCI)341999-12-012012-08-20
Recombinant Human Interferon Beta-1a (Avonex) for the Treatment of Patients With HTLV-1-Associated Myelopathy (HAM)
Recombinant human interferon beta-1a - HTLV-I Infection, Spinal Cord Disease
Phase 2CompletedNational Institute of Neurological Disorders and Stroke (NINDS)121998-09-012008-03-04
Evaluation of Patients With HAM/TSP
HTLV-I Infection, Tropical Spastic Paraparesis
RecruitingNational Institute of Neurological Disorders and Stroke (NINDS)7501998-04-062026-10-27
Assessment of Patients With Multiple Sclerosis (MS)
Herpesviridae Infection, HTLV-I Infection
CompletedNational Institute of Neurological Disorders and Stroke (NINDS)13881976-01-232017-07-02

Narrower conditions

HTLV-I Infections (5)  ·  Paraparesis, Tropical Spastic (4)  ·  Diabetes Mellitus, Insulin-Dependent, 10 (1)  ·  Epstein-Barr Virus Infections (1)  ·  Herpesviridae Infections (1)  ·  Leukemia, T-Cell (1)  ·  Leukemia-Lymphoma, Adult T-Cell (1)  ·  Multiple Sclerosis (1)  ·  Spinal Cord Diseases (1)  ·  Vasculitis (1)  ·  Virus Diseases (1)

Broader conditions

Deltaretrovirus Infections (5)  ·  Immune System Diseases (5)  ·  Immunologic Deficiency Syndromes (5)  ·  Infections (5)  ·  RNA Virus Infections (5)  ·  Retroviridae Infections (5)  ·  Central Nervous System Diseases (4)  ·  Central Nervous System Infections (4)  ·  Myelitis (4)  ·  Nervous System Diseases (4)  ·  Neuroinflammatory Diseases (4)  ·  Virus Diseases (4)  ·  Spinal Cord Diseases (3)  ·  Autoimmune Diseases (1)  ·  Autoimmune Diseases of the Nervous System (1)

Interventions

Daclizumab (1)  ·  Raltegravir Potassium (1)

Sponsors

National Institute of Neurological Disorders and Stroke (NINDS) (4)  ·  National Cancer Institute (NCI) (1)

Countries

United States (5)

Top investigators

Steven Jacobson, Ph.D. (2)  ·  Thomas Waldmann, M.D. (1)

Results publications

PMID 34562313